These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21618595)

  • 1. HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma.
    Zhang QL; Luo CL; Wu XH; Wang CY; Xu X; Zhang YY; Liu Q; Shen SL
    J Cell Biochem; 2011 Oct; 112(10):2910-9. PubMed ID: 21618595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.
    Jiang XL; Zhang Y; Tan B; Luo CL; Wu XH
    Neoplasma; 2014; 61(4):416-23. PubMed ID: 24645843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.
    Lin CP; Liu JD; Chow JM; Liu CR; Liu HE
    Anticancer Drugs; 2007 Feb; 18(2):161-70. PubMed ID: 17159602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells.
    Wang Q; Luo C; Wu X; Du H; Song X; Fan Y
    J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
    Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
    Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hepaCAM and its effect on proliferation of tumor cells in renal cell carcinoma.
    Xun C; Luo C; Wu X; Zhang Q; Yan L; Shen S
    Urology; 2010 Apr; 75(4):828-34. PubMed ID: 20110109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27(kip1) levels.
    D'Agnano I; Valentini A; Fornari C; Bucci B; Starace G; Felsani A; Citro G
    Oncogene; 2001 May; 20(22):2814-25. PubMed ID: 11420693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon beta increases c-Myc proteolysis in mouse monocyte/macrophage leukemia cells.
    Hu X; Bies J; Wolff L
    Leuk Res; 2005 Nov; 29(11):1307-14. PubMed ID: 15939469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-γ mechanism inhibiting BIU-87 proliferation.
    Xu B; He Y; Wu X; Luo C; Liu A; Zhang J
    J Urol; 2012 Oct; 188(4):1346-53. PubMed ID: 22906662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
    Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
    Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human telomerase reverse transcriptase regulates cyclin D1 and G1/S phase transition in laryngeal squamous carcinoma.
    Li J; Huang X; Xie X; Wang J; Duan M
    Acta Otolaryngol; 2011 May; 131(5):546-51. PubMed ID: 21492065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
    Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
    Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
    Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
    Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
    Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells.
    Lee LH; Moh MC; Zhang T; Shen S
    J Cell Biochem; 2009 Aug; 107(6):1129-38. PubMed ID: 19507233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.